Lambertville, NJ, United States
Strides Inc. recalls
1 recall recorded since 2018, most recently on 24 August 2020. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0
Terminated Class II Drugs
- Recall started
- 24 August 2020
- Terminated
- 11 January 2022
- Reason
- Failed Dissolution Specifications
- Distribution
- nationwide
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0001-2021
- Strides Pharma Inc.Potassium Chloride Extended-Release Tablets, USP 8mEq (600 mg) 100 Tablets Rx Only Manufactured by: Strides Pharma Science Limited Bengaluru -562106 India Distributed by: Strides Pharma Inc., East Br
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.